Chapter 11. Drug Treatment: Cholinesterase Inhibitors
- Alistair Burns3,
- Bengt Winblad4
Published Online: 19 SEP 2006
DOI: 10.1002/0470010568.ch11
Copyright © 2006 John Wiley & Sons, Ltd
Book Title
Severe Dementia
Additional Information
How to Cite
Woodward, M. and Feldman, H. H. (2006) Drug Treatment: Cholinesterase Inhibitors, in Severe Dementia (eds A. Burns and B. Winblad), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/0470010568.ch11
Editor Information
- 3
Department of Old Age Psychiatry, University of Manchester, Education and Research Centre, Wythenshawe Hospital, Manchester M23 9Lt, UK
- 4
Division of Geriatric Medicine, Karolinska Institute, Neurotec B 84, Karolinska University Hospital, SE-14186 Stockholm, Sweden
Publication History
- Published Online: 19 SEP 2006
- Published Print: 21 APR 2006
ISBN Information
Print ISBN: 9780470010549
Online ISBN: 9780470010563
- Summary
- Chapter
Keywords:
- drug treatment - cholinesterase inhibitors;
- therapy benefits measurement;
- Goal Attainment Scaling;
- add-on therapy;
- Ginkgo biloba
Summary
This chapter contains sections titled:
Introduction
Acetylcholinesterase inhibitors in use
Measuring benefits of therapy
Efficacy of anticholinesterases in severe Alzheimer's disease
Add-on therapy
Head-to-head studies
Predictors of response
When and how should a cholinesterase inhibitor be trialled in severe dementia?
Future developments
References